Amneal Pharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 4.18% vs -4.80% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 44.72% vs 218.84% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "724.50",
          "val2": "695.40",
          "chgp": "4.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "174.10",
          "val2": "157.70",
          "chgp": "10.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "65.10",
          "val2": "56.90",
          "chgp": "14.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.70",
          "val2": "-2.30",
          "chgp": "-17.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "35.60",
          "val2": "24.60",
          "chgp": "44.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "157.40%",
          "val2": "140.30%",
          "chgp": "1.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.73% vs 8.20% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -51.75% vs 80.89% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,794.00",
          "val2": "2,393.60",
          "chgp": "16.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "589.50",
          "val2": "492.40",
          "chgp": "19.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "258.60",
          "val2": "210.60",
          "chgp": "22.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-104.00",
          "val2": "-100.60",
          "chgp": "-3.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-73.90",
          "val2": "-48.70",
          "chgp": "-51.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "126.40%",
          "val2": "109.90%",
          "chgp": "1.65%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

724.50

695.40

4.18%

Operating Profit (PBDIT) excl Other Income

174.10

157.70

10.40%

Interest

65.10

56.90

14.41%

Exceptional Items

-2.70

-2.30

-17.39%

Consolidate Net Profit

35.60

24.60

44.72%

Operating Profit Margin (Excl OI)

157.40%

140.30%

1.71%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.18% vs -4.80% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 44.72% vs 218.84% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2,794.00

2,393.60

16.73%

Operating Profit (PBDIT) excl Other Income

589.50

492.40

19.72%

Interest

258.60

210.60

22.79%

Exceptional Items

-104.00

-100.60

-3.38%

Consolidate Net Profit

-73.90

-48.70

-51.75%

Operating Profit Margin (Excl OI)

126.40%

109.90%

1.65%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 16.73% vs 8.20% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -51.75% vs 80.89% in Dec 2023

All Annual Results